Benzyl Isothiocyanate Inhibits HNSCC Cell Migration and Invasion, and Sensitizes HNSCC Cells to Cisplatin

REFERENCES

• Sayed , S I , Dwivedi , R C , Katna , R , Garg , A Pathak , K A . 2011 . Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer . Oral Oncol , 47 : 237 – 243 .
   PubMed Web of Science ®Google Scholar
• de Andrade , D A and Machiels , J P . 2012 . Treatment options for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, who progress after platinum-based chemotherapy . Current Opinion in Oncology , 24 : 211 – 217 .
   PubMed Web of Science ®Google Scholar
• Kurzweg , T , Mockelmann , N , Laban , S and Knecht , R . 2012 . Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year's literature . European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies , 269 : 2157 – 2167 .
   PubMed Web of Science ®Google Scholar
• Price , K A and Cohen , E E . 2012 . Current treatment options for metastatic head and neck cancer . Current Treatment Options in Oncology , 13 : 35 – 46 .
   PubMed Web of Science ®Google Scholar
• Lee , D H , Kim , M J , Roh , J L , Kim , S B Choi , S H . 2012 . Distant metastases and survival prediction in head and neck squamous cell carcinoma . Otolaryngology—Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery , 147 : 870 – 875 .
   PubMed Web of Science ®Google Scholar
• Yoo , G H , Piechocki , M P , Ensley , J F , Nguyen , T Oliver , J . 2002 . Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot . Clin Cancer Res , 8 : 3910 – 3921 .
   PubMed Web of Science ®Google Scholar
• Chen , Z G . 2009 . The cancer stem cell concept in progression of head and neck cancer . J Oncol , 2009 : 894064
   PubMedGoogle Scholar
• Bourguignon , L Y , Earle , C , Wong , G , Spevak , C C and Krueger , K . 2012 . Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells . Oncogene , 31 : 149 – 160 .
   PubMed Web of Science ®Google Scholar
• Nakamura , Y . 2009 . Chemoprevention by isothiocyanates: molecular basis of apoptosis induction . Forum Nutr , 61 : 170 – 181 .
   PubMed Web of Science ®Google Scholar
• Nakamura , Y and Miyoshi , N . 2010 . Electrophiles in foods: the current status of isothiocyanates and their chemical biology . Biosci Biotechnol Biochem , 74 : 242 – 255 .
   PubMed Web of Science ®Google Scholar
• Wu , X , Zhou , Q H and Xu , K . 2009 . Are isothiocyanates potential anti-cancer drugs? . Acta Pharmacol Sin , 30 : 501 – 512 .
   PubMed Web of Science ®Google Scholar
• Cheung , K L and Kong , A N . 2009 . Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention . Aaps J , 12 : 87 – 97 .
   PubMed Web of Science ®Google Scholar
• Mi , L , Hood , B L , Stewart , N A , Xiao , Z Govind , S . 2011 . Identification of potential protein targets of isothiocyanates by proteomics . Chem Res Toxicol , 24 : 1735 – 1743 .
   PubMed Web of Science ®Google Scholar
• Mi , L , Xiao , Z , Veenstra , T D and Chung , F L . 2011 . Proteomic identification of binding targets of isothiocyanates: A perspective on techniques . J Proteomics , 74 : 1036 – 1044 .
   PubMed Web of Science ®Google Scholar
• Hutzen , B , Willis , W , Jones , S , Cen , L Deangelis , S . 2009 . Dietary agent, benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cells . Cancer Cell Int , 9 : 24
   PubMed Web of Science ®Google Scholar
• Zhang , R , Loganathan , S , Humphreys , I and Srivastava , S K . 2006 . Benzyl isothiocyanate-induced DNA damage causes G2/M cell cycle arrest and apoptosis in human pancreatic cancer cells . J Nutr , 136 : 2728 – 2734 .
   PubMed Web of Science ®Google Scholar
• Boreddy , S R , Sahu , R P and Srivastava , S K . 2011 . Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-alpha/VEGF/Rho-GTPases: pivotal role of STAT-3 . PLoS One , 6 : e25799
   PubMed Web of Science ®Google Scholar
• Warin , R , Chambers , W H , Potter , D M and Singh , S V . 2009 . Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate . Cancer Res , 69 : 9473 – 9480 .
   PubMed Web of Science ®Google Scholar
• Warin , R , Xiao , D , Arlotti , J A , Bommareddy , A and Singh , S V . 2010 . Inhibition of human breast cancer xenograft growth by cruciferous vegetable constituent benzyl isothiocyanate . Mol Carcinog , 49 : 500 – 507 .
   PubMed Web of Science ®Google Scholar
• Amornphimoltham , P , Patel , V , Sodhi , A , Nikitakis , N G Sauk , J J . 2005 . Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck . Cancer Res , 65 : 9953 – 9961 .
   PubMed Web of Science ®Google Scholar
• Zhao , L , Au , JL-S and Wientjes , M G . 2010 . Comparison of methods for evaluating drug–drug interaction . Frontieer Bioscience , 2 : 241 – 249 .
   Google Scholar
• Mandal , M , Myers , J N , Lippman , S M , Johnson , F M Williams , M D . 2008 . Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features . Cancer , 112 : 2088 – 2100 .
   PubMed Web of Science ®Google Scholar
• Nijkamp , M M , Span , P N , Hoogsteen , I J , van der Kogel , A J Kaanders , J H . 2011 . Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients . Radiother Oncol , 99 : 344 – 348 .
   PubMed Web of Science ®Google Scholar
• Judson , I and Kelland , L R . 2000 . New developments and approaches in the platinum arena . Drugs , 59 ( Suppl 4 ) : 29 – 36 . discussion 7–8
   PubMed Web of Science ®Google Scholar
• Giaccone , G . 2000 . Clinical perspectives on platinum resistance . Drugs , 59 ( Suppl 4 ) : 9 – 17 . discussion 37–38
   PubMed Web of Science ®Google Scholar
• Siddik , Z H . 2003 . Cisplatin: mode of cytotoxic action and molecular basis of resistance . Oncogene , 22 : 7265 – 7279 .
   PubMed Web of Science ®Google Scholar
• Mishima , M , Samimi , G , Kondo , A , Lin , X and Howell , S B . 2002 . The cellular pharmacology of oxaliplatin resistance . Eur J Cancer , 38 : 1405 – 1412 .
   PubMed Web of Science ®Google Scholar
• Keski-Santti , H , Atula , T , Tikka , J , Hollmen , J Makitie , A A . 2007 . Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue . Oral Oncol , 43 : 1007 – 1013 .
   PubMed Web of Science ®Google Scholar
• Chung , F L , Jiao , D , Getahun , S M and Yu , M C . 1998 . A urinary biomarker for uptake of dietary isothiocyanates in humans . Cancer Epidemiol Biomarkers Prev , 7 : 103 – 108 .
   PubMed Web of Science ®Google Scholar
• Sehrawat , A and Singh , S V . 2011 . Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells . Cancer Prev Res (Phila) , 4 : 1107 – 1117 .
   PubMed Web of Science ®Google Scholar
• Steck , S E , Gammon , M D , Hebert , J R , Wall , D E and Zeisel , S H . 2007 . GSTM1, GSTT1, GSTP1, and GSTA1 polymorphisms and urinary isothiocyanate metabolites following broccoli consumption in humans . J Nutr , 137 : 904 – 909 .
   PubMed Web of Science ®Google Scholar
• Lamy , E , Scholtes , C , Herz , C and Mersch-Sundermann , V . 2011 . Pharmacokinetics and pharmacodynamics of isothiocyanates . Drug Metab Rev , 43 : 387 – 407 .
   PubMed Web of Science ®Google Scholar
• Satelli , A and Li , S . 2011 . Vimentin in cancer and its potential as a molecular target for cancer therapy . Cellular and molecular life sciences: CMLS , 68 : 3033 – 3046 .
   PubMed Web of Science ®Google Scholar
• Delord , J P , Puozzo , C , Lefresne , F and Bugat , R . 2009 . Combination chemotherapy of vinorelbine and cisplatin: a phase I pharmacokinetic study in patients with metastatic solid tumors . Anticancer Research , 29 : 553 – 560 .
   PubMed Web of Science ®Google Scholar
• Ricart , A D , Berlin , J D , Papadopoulos , K P , Syed , S Drolet , D W . 2008 . Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors . Clin Cancer Res , 14 : 7947 – 7955 .
   PubMed Web of Science ®Google Scholar